Medication info
Rivastatin Tablets 20 Milligrams (Simvastatin)

Rivastatin Tablets 20 Milligrams (Simvastatin)

Prescription medicationTabletOral
Ingredient · strength
Simvastatin›20mg / 1 tablet
Manufacturer / importer
Poonglim Pharmaceutical Co., Ltd.
Appearance
Yellowish-brown oval film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 201306445 · Approved 2013.03.22 · Insurance code 649001030

Summary

Main use
Improvement of hyperlipidemia (including familial hyperlipidemia in children); prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of the risk of cardiovascular disease Adult patients at high risk of coronary heart disease events because of a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. The recommended dose is 5 ~ 40 mg of this medicine once daily in the evening. Before starting treatment, adjust the dose appropriately according to the initial LDL-cholesterol level, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, the 80 mg dose of this medicine, particularly during the first year of treatment, should be given only to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer to the information below for recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, patients with homozygous familial hypercholesterolemia should receive 40 mg of this medicine once daily in the evening. This medicine should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or if other lipid-lowering treatments are unavailable. (2) In elderly patients, the maximum cholesterol-lowering effect may be achieved with a daily dose of 20 mg of this medicine. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this medicine is administered concomitantly to patients receiving verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg per day. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this medicine is administered concomitantly to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg per day. (5) Concomitant administration with other lipid-lowering agents This medicine is effective when administered alone or in combination with a bile acid sequestrant. When this medicine is administered concomitantly with a fibrate (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine must not exceed 10 mg per day. (6) Administration to patients with renal impairment Because this medicine is not excreted extensively by the kidneys, dose adjustment is not required in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, start with an initial dose of 5 mg per day and monitor closely.
Child dose
Pediatric patients (10 ~ 17 years) with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Ingredients

Manufacturer
Poonglim Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia (including familial hyperlipidemia in children); prevention of cardiovascular disease

  • Coronary heart disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • other cerebrovascular diseases
  • hyperlipidemia
  • primary hypercholesterolemia
  • mixed dyslipidemia
  • dysbetalipoproteinemia
  • hypertriglyceridemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medication is used to reduce the risk of cardiovascular diseases. It particularly helps to lower the risk of heart attack and stroke in adult patients with a history of coronary heart disease, diabetes, peripheral vascular disease, and stroke. It is also effective in treating hyperlipidemia, reducing cholesterol and LDL cholesterol levels, and increasing HDL cholesterol to improve blood lipid balance. For pediatric patients with familial hypercholesterolemia, it is used in conjunction with diet to help control blood lipid levels. This drug plays an important role in maintaining cardiovascular health and reducing the risk of related diseases.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of the risk of cardiovascular disease Adult patients at high risk of coronary heart disease events because of a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. The recommended dose is 5 ~ 40 mg of this medicine once daily in the evening. Before starting treatment, adjust the dose appropriately according to the initial LDL-cholesterol level, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, the 80 mg dose of this medicine, particularly during the first year of treatment, should be given only to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer to the information below for recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, patients with homozygous familial hypercholesterolemia should receive 40 mg of this medicine once daily in the evening. This medicine should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or if other lipid-lowering treatments are unavailable. (2) In elderly patients, the maximum cholesterol-lowering effect may be achieved with a daily dose of 20 mg of this medicine. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this medicine is administered concomitantly to patients receiving verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg per day. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this medicine is administered concomitantly to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg per day. (5) Concomitant administration with other lipid-lowering agents This medicine is effective when administered alone or in combination with a bile acid sequestrant. When this medicine is administered concomitantly with a fibrate (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine must not exceed 10 mg per day. (6) Administration to patients with renal impairment Because this medicine is not excreted extensively by the kidneys, dose adjustment is not required in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, start with an initial dose of 5 mg per day and monitor closely.

Child dose

Pediatric patients (10 ~ 17 years) with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Precautions

This medication may cause muscle issues, so if muscle pain or weakness occurs, consult a doctor immediately. Especially at high doses, there is an increased risk of muscle damage; therefore, caution should be exercised. It may affect liver function, so it should not be taken if there is liver disease or abnormally high liver enzymes. Pregnant women, women who may become pregnant, and nursing mothers should not take this medication. Since it can interact with other drugs, be sure to inform your healthcare provider of any medications you are taking. Elderly patients and those with kidney or thyroid issues should use this medication carefully. Regular monitoring of liver function and muscle condition during the medication period is recommended. Serious side effects may occur with overdose, so prescribed dosages should be strictly adhered to. Store in a place out of reach of children and keep in the original container.

Side effects

  • Myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 92 more
  • upper respiratory infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramps
  • arthralgia
  • dysgeusia
  • ocular motility disorder
  • facial paresis
  • tremor
  • sensory disturbance
  • peripheral neuropathy
  • peripheral nerve palsy
  • mental disorder
  • anxiety
  • sleep disorder
  • nightmares
  • depression
  • cognitive impairment
  • myasthenia gravis
  • ocular myasthenia
  • hepatitis
  • liver dysfunction
  • jaundice
  • alopecia
  • pruritus
  • skin changes
  • lichenoid drug rash
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • cataract progression
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GTP
  • increased bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus erythematosus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • fatigue
  • dyspnea
  • toxic epidermal necrolysis
  • mucocutaneous syndrome
  • pancreatitis
  • fatal liver failure
  • cholestatic jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • loss of appetite
  • vomiting
  • limb sensory numbness
  • paresthesia
  • cold sensation
  • muscle weakness
  • thrombocytopenia
  • lupus erythematosus-like syndrome
  • interstitial lung disease
  • muscle weakness
  • myalgia
  • vomiting
  • mucus stools

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air from entering, and it is best stored at room temperature between 1 and 30 degrees Celsius. This helps to maintain the drug's effectiveness.

Appearance and packaging

Appearance

Yellowish-brown oval film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.